Mark Cuban Shares His Plan For Fixing Drug Prices in America | The Real Eisman Playbook Ep 50
TL;DR
Mark Cuban details how his company Cost Plus Drugs undercuts the pharmaceutical industry by selling medications at cost plus 15%, while exposing how Pharmacy Benefit Managers (PBMs) force the sickest Americans to pay inflated prices that subsidize employer rebates and premiums.
💊 The Cost Plus Business Model 3 insights
Radical transparency with fixed 15% markup
Cost Plus Drugs publishes actual acquisition costs and applies a standard 15% markup, offering medications like the Stelara biosimilar Stargeza for $365 compared to $30,000 quarterly charges elsewhere.
Bypassing traditional pharmacy networks
The company eliminates Pharmacy Benefit Managers (PBMs) entirely, shipping generic, biosimilar, and select brand medications directly to consumers with no hidden fees or rebate schemes.
Doctors ignore cost conversations
Cuban notes physicians rarely discuss affordability, simply asking which pharmacy patients use rather than explaining that identical medications might cost $1,000 through insurance or $100 through Cost Plus.
🔄 The PBM Rebate Trap 3 insights
Patients pay rebates during deductible phase
PBMs extract rebates from manufacturers (e.g., $400 on a $1,000 drug) for formulary placement, but patients paying deductibles are charged the full retail price while PBMs and employers pocket the rebate difference.
Multiple layers of hidden fees
Group purchasing organizations owned by PBMs take a 10-20% 'vig' from rebates before passing remainder to employers, who use these funds to lower premiums rather than reduce patient drug costs.
Sickest patients subsidize the healthy
Because rebates only generate when prescriptions are filled, patients with chronic illnesses meeting deductibles effectively pay inflated prices that subsidize premium reductions for healthier employees.
⚠️ Systemic Healthcare Dysfunction 3 insights
Hospitals as subprime lenders
When patients cannot afford $1,500-$5,000 deductibles, hospitals must loan them money to access insurance payments, knowing many patients will default but needing to unlock insurer funds.
Insurance payment games drive facility fees
Insurers underpay, late-pay, and audit hospitals, forcing providers to invent facility fees and location-based pricing surcharges to cover losses from delayed or denied reimbursements.
Fatal consequences of cost rationing
Cuban cites a truck driver who skipped heart medication due to unaffordable deductible costs, causing him to pass out while driving and kill four people—a tragedy caused by the rebate-driven pricing structure.
Bottom Line
Traditional insurance plans force the sickest patients to pay hidden rebate costs during their deductible phase, making transparent alternatives like Cost Plus Drugs not just cheaper but ethically necessary to prevent deadly medication rationing.
More from Steve Eisman
View all
The Only Health Insurance Stock You Can Own with Michael Ha | The Real Eisman Playbook Episode 51
Baird analyst Michael Ha reveals how United Healthcare's Optum Health division faces structural collapse due to new Medicare risk adjustment rules exposing years of aggressive patient coding, while delusional investors cling to the hope that traditional insurance repricing can offset permanent revenue impairment.
The Iran War Crisis: Ex-CIA Analyst Helima Croft on Oil Shock & Energy Risk | The Weekly Wrap
Former CIA analyst Helima Croft warns that the Iran war has triggered a genuine energy crisis with the Strait of Hormuz effectively closed, 6.7 million barrels of daily production shut in due to full storage tanks, and depleted Western strategic reserves insufficient to cover more than a few weeks of disruption.
Private Credit Cracks, The AI "Boogeyman" & Why Crypto is for Boomers | The Real Eisman Playbook
Steve Eisman, Glenn Shore, and Dwight Collins dissect the recent panic in private credit markets, focusing on Blue Owl's failed BDC restructuring and the structural relationship between direct lending and private equity, while warning that alternative asset managers have become uninvestable due to complexity and headline-driven retail outflow risks.
The Next Financial Crisis? Private Equity, Private Credit & Life Insurance | Real Eisman Playbook
Forensic accountant Tom Gober warns that private equity firms have transformed the life insurance industry into a highly leveraged shadow banking system by exploiting weak state regulations and offshore captive reinsurance schemes, creating systemic risks that could trigger the next financial crisis when credit conditions deteriorate.